Cargando…
Fluralaner 5.46% (w/w) flavored chewable tablet (Bravecto(®) 1-Month) is effective for treatment of canine generalized demodicosis
BACKGROUND: Orally administered fluralaner (13.64% w/w) is effective for treating canine generalized demodicosis. A study was initiated to assess the efficacy of a novel 5.46% w/w fluralaner chewable tablet formulation for monthly administration in the treatment of this disease. METHODS: Client-owne...
Autores principales: | Rohdich, Nadja, Meyer, Leon, Guerino, Frank |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917636/ https://www.ncbi.nlm.nih.gov/pubmed/35279216 http://dx.doi.org/10.1186/s13071-022-05213-x |
Ejemplares similares
-
Correction to: Fluralaner 5.46% (w/w) favored chewable tablet (Bravecto® 1-Month) is effective for treatment of canine generalized demodicosis
por: Rohdich, Nadja, et al.
Publicado: (2022) -
Efficacy of fluralaner chewable tablets (Bravecto(®)) against Asian longhorned tick (Haemaphysalis
longicornis) infestations of dogs
por: Petersen, Melissa, et al.
Publicado: (2023) -
A European field assessment of the efficacy of fluralaner (Bravecto(®)) chewable and spot-on formulations for treatment of dogs with generalized demodicosis
por: Petersen, Ivo, et al.
Publicado: (2020) -
Efficacy of fluralaner (Bravecto™ chewable tablets) for the treatment of naturally acquired Linognathus setosus infestations on dogs
por: Kohler-Aanesen, Heike, et al.
Publicado: (2017) -
Prevention of transmission of Babesia canis by Dermacentor reticulatus ticks to dogs treated orally with fluralaner chewable tablets (Bravecto™)
por: Taenzler, Janina, et al.
Publicado: (2015)